Zepbound patient assistance program searches usually lead to Lilly Cares, Lilly’s free-medicine foundation, but Zepbound is not on the Lilly Cares list as of October 2026.[1] The realistic lower-cost routes are LillyDirect self-pay from $299 a month, the $25 savings card if a commercial plan covers Zepbound, and $50 a month through the Medicare GLP-1 Bridge for eligible Medicare members.[4][3][5]
Prices and program terms checked October 2026. They change often; confirm with the manufacturer or your plan.
Zepbound contains tirzepatide; see our tirzepatide profile.
Is Zepbound part of Lilly Cares?
No. Lilly Cares provides only the Lilly medicines on its published list. The October 2026 list includes Trulicity, several insulins and a range of specialty medicines, but neither Zepbound nor Mounjaro.[1]
Lilly Cares generally serves people who have no insurance or have Medicare Part D, whose household income falls under limits set at 300% to 500% of the federal poverty level depending on the medicine, and who are not on Medicaid, full Extra Help or VA benefits.[2] Those rules matter only if your prescriber chooses a medicine that is on the list.
If a company offers to enroll you in a “Zepbound assistance program” for a fee, be cautious. Lilly Cares does not charge for enrollment and says it is not affiliated with paid third parties.[2]
Lower-cost Zepbound options compared
| Option | What you pay | Who qualifies |
|---|---|---|
| LillyDirect self-pay (vial or KwikPen) | $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg, on-time refills)[4] | Anyone with a prescription paying cash |
| Savings card, plan covers Zepbound | As little as $25 for up to 3 months[3] | Commercial insurance only |
| Savings card, plan excludes Zepbound | $499 (single-dose pen) or $299 to $449 (KwikPen)[3] | Commercial insurance only |
| Medicare GLP-1 Bridge | $50 a month, KwikPen only[5] | Eligible Part D members, weight management |
| Medicare Part D, sleep apnea | Your plan’s cost-sharing[6] | Part D members with moderate to severe OSA |
| Lilly Cares | Not available[1] | n/a |
Option 1: LillyDirect self-pay
For people without insurance, or whose plan excludes weight-loss drugs, LillyDirect is the official low-price route. A month of vials (four) or one KwikPen costs $299 at the 2.5 mg starting dose, $399 at 5 mg and $449 at 7.5 to 15 mg. The $449 price requires refilling within 45 days of the last delivery; late refills cost $499 at 7.5 mg and $699 at 10 to 15 mg.[4] Vials need syringes, and the KwikPen needs pen needles, sold separately.[4]
Full breakdown: Zepbound cost without insurance.
Option 2: The Zepbound Savings Card
If you have commercial insurance that covers the Zepbound single-dose pen, the card can bring a 1-, 2- or 3-month fill down to as little as $25, with Lilly paying up to $100 per month and $1,300 a year. If your commercial plan excludes Zepbound, the card lowers the single-dose pen to as low as $499 a month or the KwikPen to $299 to $449.[3] The card excludes all government insurance and expires December 31, 2026.[3]
Full terms: Zepbound savings card.
Option 3: Medicare GLP-1 Bridge
This temporary CMS program runs from July 1, 2026 through December 31, 2027. Eligible Part D members prescribed Zepbound to lose weight and keep it off pay $50 a month for the KwikPen. Vials and single-dose pens are not covered.[5]
Eligibility depends on BMI and health conditions at the time GLP-1 treatment started: a BMI of 35 or more; or 30 or more with heart failure with preserved ejection fraction, uncontrolled high blood pressure or stage 3a or worse kidney disease; or 27 or more with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease.[5] Prior authorization is required and there is no appeals process, though prescribers can resubmit.[5]
People who already received a GLP-1 through Part D in 2026, and people with type 2 diabetes or sleep apnea, are routed to their regular Part D plan instead.[6] See does Medicare cover Zepbound?
Option 4: Medicaid
Medicaid coverage of weight-loss drugs is optional for states. KFF reports that the Medicaid part of CMS’s BALANCE model, which offers states discounted GLP-1 pricing, began rolling out on May 1, 2026, with state participation voluntary.[7] Ask your state Medicaid office or plan whether Zepbound is covered and what prior authorization it needs.
Option 5: Sleep apnea coverage
Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity.[8] Some plans that exclude weight-loss drugs still cover Zepbound for sleep apnea with a sleep study and prior authorization, and Medicare Part D plans can cover it for this use.[6] If you have a sleep apnea diagnosis, ask your prescriber whether this route applies. See Zepbound for sleep apnea.
Which option fits your situation
You have no insurance. LillyDirect self-pay is the official route. Budget about $5,600 to $5,800 for a year at the $449 refill price after the starting doses, more if refills run late.[4]
You have employer insurance that covers weight-loss drugs. Get prior authorization, then use the savings card for as little as $25 a fill, up to Lilly’s $1,300 yearly cap.[3]
You have employer insurance that excludes weight-loss drugs. Compare the not-covered card tier for the KwikPen ($299 to $449) with LillyDirect self-pay; the prices are similar. If you have sleep apnea, ask whether your plan covers Zepbound for that use.[3][4]
You have Medicare. For weight management, check whether you meet the GLP-1 Bridge BMI and health criteria. For sleep apnea, ask your Part D plan.[5][6]
You have Medicaid. Ask your state program or Medicaid plan; coverage differs by state.[7]
Your income is low and none of these work. There is no free Zepbound program, but your prescriber can review whether another medicine, including one on the Lilly Cares list, fits your needs.[1]
Useful phone numbers
- Zepbound savings program: 1-866-923-1953[3]
- LillyDirect: 1-844-559-3471[4]
- Lilly Cares (listed medicines only): 1-800-545-6962[2]
For every Lilly program side by side, see our tirzepatide coupon guide.
